LABU

$317.20 1.76% $5.50
Aug 21, 2026 04:00 AM

LABU, or Direxion Daily S&P Biotech Bull 3X Shares, is an exchange-traded fund (ETF) designed to provide three times the daily return of the S&P Biotechnology Select Industry Index. It aims to deliver 3x the daily performance of the underlying index.

Scroll or pinch to zoom · drag to pan the chart

Updating chart…

Price chart bar size:

Share on:

Asset Summary

Loading summary…

Asset Performance Metrics and Risk Characteristics:

Metrics below use daily returns for Jan 1, 2026 – Aug 23, 2026 (YTD).

Understanding asset performance is crucial for evaluating investment quality and making informed decisions. Metrics like trailing return and drawdown provide insights into how an asset has performed over time, its volatility, and the efficiency of its returns relative to risk. Performance indicators help assess the stability, risk, and reward of an investment, allowing investors and portfolio managers to make comparisons and strategize accordingly.

Asset Technical Analysis

Technical analysis involves evaluating an asset's price and volume data to forecast future movements and make informed trading decisions. Using indicators such as moving averages, pivot levels, momentum studies, and candlestick pattern scans can clarify trend strength and volatility. The tabs below summarize moving averages, pivots, technical indicators, candlestick patterns, and recent prices for this symbol.

Analysis

Moving Averages

Moving Averages are commonly used to smooth out price data and identify trends over a specific period. Here’s a summary of the latest moving averages for various periods:

  • SMA (Simple Moving Average): Reflects the average price over a specific number of periods.
  • EMA (Exponential Moving Average): Gives more weight to recent prices, making it more responsive to new information.
  • WMA (Weighted Moving Average): Assigns a weight to each price, emphasizing more recent prices.
  • WEMA (Weighted Exponential Moving Average): Combines elements of both WMA and EMA for a more responsive moving average.

Unlock Your LABU Trading Now

Achieve superior trading results with OHLCX.com. Our platform provides expert analysis and actionable insights for LABU, utilizing the latest technology to refine your investment approach. Elevate your trading approach instantly now and see the impact on your trading success!

Explore Insights Now

Frequently Asked Questions

Investors can purchase shares of LABU through a brokerage account. It is traded on major stock exchanges under the ticker symbol "LABU" and can be bought and sold like other stocks and ETFs.

LABU typically distributes dividends on a quarterly basis. These dividends are derived from income produced by the underlying securities, although leveraged ETFs often have lower yields compared to non-leveraged funds.

Factors influencing LABU’s performance include movements in the biotechnology sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. The ETF’s daily rebalancing and compounding effects also impact performance.

Risks include high volatility and the potential for significant losses due to LABU’s leveraged exposure. The ETF’s performance is highly sensitive to daily changes in the biotech sector, and leverage can amplify both gains and losses.

LABU rebalances its holdings daily to maintain its 3x leverage ratio relative to the S&P Biotechnology Select Industry Index. This daily rebalancing aims to achieve the 3x daily performance, though it can lead to performance deviations over longer periods due to the effects of compounding.

Yes, LABU can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it’s crucial to assess how it fits within your overall investment strategy and risk tolerance.

Key performance metrics for LABU include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABU targets 3x the daily performance of the S&P Biotechnology Select Industry Index.

LABU is managed by Direxion and seeks to achieve its investment objective by using financial instruments such as derivatives, including futures contracts, options, and swap agreements. It maintains its 3x leverage through daily rebalancing.

LABU has an expense ratio of approximately 1.04%. This fee reflects the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

LABU aims to deliver three times the daily return of the S&P Biotechnology Select Industry Index. Due to its leveraged nature, its performance can significantly deviate from the index over periods longer than one day due to compounding effects and daily rebalancing.

Optimize Your LABU Trading Now

Experience the future of trading with ohlcx.com. Our advanced system delivers in-depth analysis and insights for LABU, utilizing state-of-the-art technical tools and strategies. Boost your investment success with us and see how we can elevate your trading results!

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Market data is provided in near real-time when available, but we do not guarantee its accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.